Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION an – CDC

by

  1. Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION an CDC
  2. Monovalent XBB.1.5 vaccine shows 51% protection against COVID hospitalization University of Minnesota Twin Cities
  3. The fall COVID-19 shot’s effectiveness, and other respiratory virus news this week The Globe and Mail
  4. Latest COVID-19 vaccines reduce hospitalization risk by around half Healio
  5. Updated COVID-19 Vaccination Effective Against ED/Urgent Care Encounters HealthDay

Read original article here

Leave a Comment